Virginia Retirement Systems’s Teva Pharmaceuticals TEVA Stock Holding History

Virginia Retirement Systems’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-55,600	Closed	-$1.2M	–	1119
2018 Q3	$1.2M	Buy	55,600 +3,500	+7%	+$81.3K	0.01%	646
2018 Q2	$1.27M	Buy	+52,100	New	+$1.06M	0.02%	610
2018 Q1	–	Sell	-26,100	Closed	-$495K	–	1056
2017 Q4	$495K	Buy	+26,100	New	+$393K	0.01%	811
2017 Q3	–	Sell	-39,300	Closed	-$1.31M	–	1118
2017 Q2	$1.31M	Hold	39,300	–	–	0.02%	588
2017 Q1	$1.26M	Sell	39,300 -12,600	-24%	-$430K	0.02%	601
2016 Q4	$1.88M	Buy	+51,900	New	+$2.07M	0.03%	426

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Virginia Retirement Systems's TEVA Position: Q4 2018 in Review

Virginia Retirement Systems sold out of Teva Pharmaceuticals (TEVA) in Q4 2018, closing a stake of 55,600 shares — an estimated $1.2M sold.

Virginia Retirement Systems first reported a position in TEVA in Q4 2016 and held it in 6 quarters. The position peaked at $1.88M in Q4 2016. 551 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

Virginia Retirement Systems reported no remaining Teva Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
Virginia Retirement Systems sold 55,600 Teva Pharmaceuticals shares in Q4 2018, an estimated $1.2M.
Virginia Retirement Systems first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 6 quarters.
Virginia Retirement Systems's Teva Pharmaceuticals position peaked at $1.88M in Q4 2016.
551 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2018.

Based on Virginia Retirement Systems's 13F filing for Q4 2018, filed 7 Feb 2019.